We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$39.7M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$34.3M
3
MRNA icon
Moderna
MRNA
+$29.3M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.3M
5
MTCH icon
Match Group
MTCH
+$9.52M

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$35.7M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
AAPL icon
Apple
AAPL
+$13.2M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.28M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$6.57M

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFLY icon
1351
Butterfly Network
BFLY
$2.36B
$678K 0.01%
64,973
+50,311
+343% +$581K
HCSG icon
1352
Healthcare Services Group
HCSG
$1.43B
$677K 0.01%
27,110
-37,334
-58% -$1.01M
TRIL
1353
DELISTED
Trillium Therapeutics Inc.
TRIL
$677K 0.01%
38,562
– –
PATK icon
1354
Patrick Industries
PATK
$2.79B
$674K 0.01%
12,134
– –
XHR
1355
Xenia Hotels & Resorts
XHR
$1.73B
$673K 0.01%
37,927
– –
SRNE
1356
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$673K 0.01%
88,173
-10,163
-10% -$86.2K
RLAY icon
1357
Relay Therapeutics
RLAY
$4.37B
$671K 0.01%
21,269
– –
SWTX
1358
DELISTED
SpringWorks Therapeutics
SWTX
$669K 0.01%
10,552
– –
LNTH icon
1359
Lantheus
LNTH
$6.57B
$669K 0.01%
26,066
– –
GVA icon
1360
Granite Construction
GVA
$5.41B
$668K 0.01%
16,882
– –
FLGT icon
1361
Fulgent Genetics
FLGT
$515M
$667K 0.01%
7,417
– –
CVET
1362
DELISTED
Covetrus, Inc. Common Stock
CVET
$667K 0.01%
36,775
– –
CORT icon
1363
Corcept Therapeutics
CORT
$12.1B
$666K 0.01%
33,849
-5,535
-14% -$116K
IRWD icon
1364
Ironwood Pharmaceuticals
IRWD
$714M
$666K 0.01%
50,961
-10,033
-16% -$130K
BANR icon
1365
Banner Corp
BANR
$2.5B
$663K 0.01%
12,017
– –
ADEA icon
1366
Adeia
ADEA
$3.16B
$662K 0.01%
132,916
– –
SPHR icon
1367
Sphere Entertainment
SPHR
$6.33B
$661K 0.01%
9,098
+2,287
+34% +$171K
QNCX icon
1368
Quince Therapeutics
QNCX
$31.8M
$661K 0.01%
36
– –
PJT icon
1369
PJT Partners
PJT
$4.36B
$660K 0.01%
8,339
-1,070
-11% -$82K
AHCO icon
1370
AdaptHealth
AHCO
$760M
$659K 0.01%
28,311
– –
ETWO
1371
DELISTED
E2open Parent Holdings
ETWO
$656K 0.01%
58,050
+39,729
+217% +$446K
CNK icon
1372
Cinemark Holdings
CNK
$4.32B
$654K 0.01%
34,063
-58,953
-63% -$1M
MGRC icon
1373
McGrath RentCorp
MGRC
$2.94B
$653K 0.01%
9,074
– –
COUR icon
1374
Coursera
COUR
$1.48B
$652K 0.01%
20,589
+15,344
+293% +$578K
CENTA icon
1375
Central Garden & Pet Co Class A
CENTA
$2.43B
$651K 0.01%
18,935
– –
53 54
55
56 57

Similar funds

BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.